Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medigen Vaccine BiologicsROCO:6547 +6.10%66 Days Inventory is 977.42 as of Dec. 2025, which is 45% above its 10-year median of 675.09. GuruFocus rates ROCO:6547 with a GF Score™ of 66/100 and a GF Value™ of NT$70.73 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, Medigen Vaccine Biologics ranks worse than 86.83% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medigen Vaccine Biologics's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medigen Vaccine Biologics's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 2.96.
Medigen Vaccine Biologics (ROCO:6547) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medigen Vaccine Biologics's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medigen Vaccine Biologics's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medigen Vaccine Biologics Days Inventory Related Terms
Medigen Vaccine Biologics Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6547 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Medigen Vaccine Biologics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medigen Vaccine Biologics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medigen Vaccine Biologics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medigen Vaccine Biologics (ROCO:6547) has a Days Inventory of 977.42 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medigen Vaccine Biologics and its competitors. This is 45% above median its historical median of 675.09. Over the past decade, Medigen Vaccine Biologics' Days Inventory has ranged from 119.85 to 4,046.35. According to the industry distribution chart, Medigen Vaccine Biologics ranks #554 out of 638 companies in the Biotechnology industry, placing it in the top 86.8%.
Is Medigen Vaccine Biologics' Days Inventory too high?
Medigen Vaccine Biologics' current Days Inventory of 977.42 is 45% above median its 10-year median of 675.09. Over the past 10 years, this metric has ranged from a low of 119.85 to a high of 4,046.35. The Biotechnology industry median Days Inventory is 183.20. Medigen Vaccine Biologics' value of 977.42 is 433.5% above this industry median. Based on the distribution chart, Medigen Vaccine Biologics ranks #554 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Medigen Vaccine Biologics has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medigen Vaccine Biologics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medigen Vaccine Biologics ranks #554 out of 638 companies for Days Inventory. This places Medigen Vaccine Biologics in the lower half of its industry. The industry median Days Inventory is 183.20. Medigen Vaccine Biologics' value of 977.42 is 433.5% above this benchmark. Historically, Medigen Vaccine Biologics' own Days Inventory has ranged from 119.85 to 4,046.35 over the past decade. While the company's 10-year median is 675.09 vs. the industry median of 183.20, Medigen Vaccine Biologics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medigen Vaccine Biologics's current Days Inventory of 977.42 is 433.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medigen Vaccine Biologics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medigen Vaccine Biologics's current Days Inventory is 977.42, which is 45% above median its own 10-year median of 675.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigen Vaccine Biologics stock overvalued right now?
Based on GuruFocus' analysis, Medigen Vaccine Biologics (ROCO:6547) is currently considered Possible Value Trap. The stock's GF Value™ is NT$70.73, compared to a current price of NT$47.80 — trading 32.4% below its estimated fair value. The current Days Inventory is 977.42, which is 45% above median its 10-year median of 675.09 and 433.5% above the Biotechnology industry median of 183.20. Medigen Vaccine Biologics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medigen Vaccine Biologics (ROCO:6547), the current Days Inventory is 977.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medigen Vaccine Biologics (ROCO:6547) Overvalued in 2026?
Based on GuruFocus' analysis, Medigen Vaccine Biologics stock appears to be undervalued.
The current stock price of NT$47.80 is trading 32.4% below its estimated GF Value™ of NT$70.73.
GuruFocus considers Medigen Vaccine Biologics to be Possible Value Trap.
Key valuation signals for ROCO:6547:
Days Inventory: 977.42 (45% above median its 10-year median of 675.09)
GF Value™: NT$70.73 vs. price of NT$47.80 (32.4% below fair value)
Industry Position: 433.5% above the Biotechnology median (#554 of 638)
No single metric tells the full story. See the ROCO:6547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medigen Vaccine Biologics Corp is engaged in the research, development and wholesale of vaccine and biopharmaceutical, medical devices wholesale and retail, etc. Its products include dengue vaccine, anti-RSV biosimilars, COVID-19 vaccines, enterovirus A71 vaccine, and influenza vaccine QIZ. It operates business only in a single industry in Taiwan.
66GF Score
Get the complete analysis for ROCO:6547
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6547 has been successfully added to your 
